hrp0097p1-183 | Sex Differentiation, Gonads and Gynaecology, and Sex Endocrinology | ESPE2023
Kvernebo Sunnergren Kjersti
, Badsberg Norup Pernille
, E. Haahr Mette
, Christiansen Peter
, Aksglaede Lise
, H. Cleemann Line
, Juul Anders
, M. Main Katharina
Background: Transgender adolescents may be treated with gender affirming hormone therapy (GAHT) consisting of gonadotropin-releasing hormone agonists (GnRHa) and cross-sex hormones. Limited data are available regarding the metabolic effects of GAHT in adolescence.Objective: To evaluate the lipid profiles and HbA1c in transgender adolescents after one year of cross-hormone treatment.Patients...